References

Citations

1. Roberts JM (2004). Pregnancy-related hypertension. In RK Creasy, R Resnik, eds., Maternal-Fetal Medicine, 5th ed., pp. 859–899. Philadelphia: Saunders.

2. Solomon CG, Seely EW (2004). Preeclampsia—Searching for the cause. New England Journal of Medicine, 350(7): 641–642.

3. Roberts JM, Cooper DW (2001). Pathogenesis and genetics of pre-eclampsia. Lancet, 357(9249): 53–56.

4. Duley L (2005). Pre-eclampsia and hypertension, search date November 2004. Online version of Clinical Evidence (14): 1776–1790.

5. Cunningham FG, et al. (2005). Maternal physiology. In Williams Obstetrics, 22nd ed., pp. 122–150. New York: McGraw-Hill.

6. Habli M, Sibai BM (2008). Hypertensive disorders of pregnancy. In RS Gibbs et al., eds., Danforth's Obstetrics and Gynecology, 10th ed., pp. 257–275. Philadelphia: Lippincott Williams and Wilkins.

7. O'Brien TE, et al. (2003). Maternal body mass index and the risk of preeclampsia: A systematic overview. Epidemiology, 14(3): 368–374.

8. Skjaerven R, et al. (2002). The interval between pregnancies and the risk of preeclampsia. New England Journal of Medicine, 346(1): 33–38.

9. Wiggins DA, Main E (2005). Outcomes of pregnancies achieved by donor egg in vitro fertilization—A comparison with standard in vitro fertilization pregnancies. American Journal of Obstetrics and Gynecology, 192(6): 2002–2008.

10. Cooper WO, et al. (2006). Major congenital malformations after first-trimester exposure to ACE inhibitors. New England Journal of Medicine, 354(23): 2443–2451.

11. American Academy of Pediatrics (2001). The transfer of drugs and other chemicals into human milk. Pediatrics, 108(3): 776–789.

12. Sibai BM (2004). Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. American Journal of Obstetrics and Gynecology, 190(6): 1520–1526.

13. Villar J, et al. (2006). World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology, 194(3): 639–649.

14. Coomarasamy A, et al. (2003). Aspirin for prevention of preeclampsia in women with historical risk factors: A systematic review. Obstetrics and Gynecology, 101(6): 1319–1332.

15. Poston L, et al. (2006). Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): Randomised placebo-controlled trial. Lancet, 367(9517): 1145–1154.

16. Rumbold AR, et al. (2006). Vitamins C and E and the risks of preeclampsia and perinatal complications. New England Journal of Medicine, 354(17): 1796–1806.

17. Sibai BM (2003). Diagnosis and management of gestational hypertension and preeclampsia. Obstetrics and Gynecology, 102(1): 191–192.

Other Works Consulted

• American College of Obstetricians and Gynecologists (2002). Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No. 33. Obstetrics and Gynecology, 99(1): 159–167.

• Duley L, et al. (2001). Antiplatelet drugs for prevention of pre-eclampsia and its consequences: Systematic review. BMJ, 322(7282): 329–333.